The Role of the Nonspecific Inflammatory Markers in Determining the Anatomic Extent of Venous Thromboembolism

被引:59
作者
Bakirci, Eftal Murat [1 ]
Topcu, Selim [2 ]
Kalkan, Kamuran [2 ]
Tanboga, Ibrahim Halil [2 ]
Borekci, Abdurrezzak [3 ]
Sevimli, Serdar [2 ]
Acikel, Mahmut [2 ]
机构
[1] Bayburt State Hosp, Dept Cardiol, TR-69000 Bayburt, Turkey
[2] Ataturk Univ, Fac Med, Dept Cardiol, Erzurum, Turkey
[3] Sifa Hosp, Dept Cardiol, Erzurum, Turkey
关键词
deep venous thrombosis; thrombosis; pulmonary embolism; C-REACTIVE PROTEIN; DEEP-VEIN THROMBOSIS; LYMPHOCYTE RATIO; ACUTE-PHASE; RISK; ASSOCIATION; PREVENTION; NEUTROPHIL; ACTIVATION; DISEASE;
D O I
10.1177/1076029613494469
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We aimed to investigate the relationship between the extent of venous thromboembolism (VTE) and nonspecific inflammatory markers such as neutrophil to lymphocyte ratio (NLR) and high-sensitivity C-reactive protein (hs-CRP). We retrospectively enrolled 77 patients with VTE (distal deep vein thrombosis [DVT], n = 19; proximal DVT, n = 32; and pulmonary thromboembolism [PTE], n = 26) and 34 healthy controls. In the performed analysis of variance, the levels of white blood cell, NLR, and hs-CRP were clearly different among the groups (control, distal and proximal DVT, and PTE) (P <.001). Especially, a significant increase from the control group to the DVT and PTE was observed in the analysis made for NLR. In the performed receiver-operating characteristic curve analysis, area under curve (AUC) = 0.849 and P <.001 were detected for NLR > 1.84. For this value, the sensitivity and specificity were determined as 88.2% and 67.6%, respectively. The NLR is an inexpensive and a readily available marker that may be effective in determining the extent of VTE, and it is useful for risk stratification in patients with VTE.
引用
收藏
页码:181 / 185
页数:5
相关论文
共 33 条
[1]  
[Anonymous], 2001, Anadolu Kardiyol Derg, V1, P48
[2]   Does the clinical presentation and extent of venous thrombosis predict likelihood and type of recurrence? A patient-level meta-analysis [J].
Baglin, T. ;
Douketis, J. ;
Tosetto, A. ;
Marcucci, M. ;
Cushman, M. ;
Kyrle, P. ;
Palareti, G. ;
Poli, D. ;
Tait, R. C. ;
Iorio, A. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2010, 8 (11) :2436-2442
[3]  
Buyukkaya E, 2012, CLIN APPL THROMB HEM
[4]   C-reactive protein and venous thromboembolism A prospective investigation in the ARIC cohort [J].
Folsom, Aaron R. ;
Lutsey, Pamela L. ;
Astor, Brad C. ;
Cushman, Mary .
THROMBOSIS AND HAEMOSTASIS, 2009, 102 (04) :615-619
[5]   Mechanisms of disease: Acute-phase proteins and other systemic responses to inflammation [J].
Gabay, C ;
Kushner, I .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (06) :448-454
[6]   Drug therapy [J].
Ginsberg, JS .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (24) :1816-1828
[7]   A Randomized Trial of Rosuvastatin in the Prevention of Venous Thromboembolism [J].
Glynn, Robert J. ;
Danielson, Eleanor ;
Fonseca, Francisco A. H. ;
Genest, Jacques ;
Gotto, Antonio M., Jr. ;
Kastelein, John J. P. ;
Koenig, Wolfgang ;
Libby, Peter ;
Lorenzatti, Alberto J. ;
MacFadyen, Jean G. ;
Nordestgaard, Borge G. ;
Shepherd, James ;
Willerson, James T. ;
Ridker, Paul M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (18) :1851-1861
[8]  
Gul M, 2012, CLIN APPL THROMB HEM
[9]   High-sensitivity C-reactive protein is not a risk factor for venous thromboembolism: the Tromso study [J].
Hald, Erin M. ;
Braekkan, Sigrid K. ;
Mathiesen, Ellisiv B. ;
Njolstad, Inger ;
Wilsgaard, Tom ;
Brox, Jan ;
Hansen, John-Bjarne .
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (08) :1189-1194
[10]   Inflammation and thrombosis in diabetes [J].
Hess, Katharina ;
Grant, Peter J. .
THROMBOSIS AND HAEMOSTASIS, 2011, 105 :S43-S54